Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Aspirin usage in patients with essential hypertension

View through CrossRef
Objective To investigate the use of aspirin in patients with essential hypertension complicated with different risk factors and clinical conditions. Method Epidemiological cross-sectional survey was used. Through face to face questionnaire, patients with essential hypertension patients in 20 cities in China were assessed for aspirin consumption. Results Total of 6483 patients with hypertension were enrolled; 3287 (50.7%) were male and other 3195 (49.3%) were female. Their mean age was 62.21 years, mean blood pressure was 142.8/86 mm Hg, mean hypertension course was 10.46 years. A total of 2301 (35.5%) patients were taking aspirin, of which 88.05% of patients were using aspirin dose 75–150 mg/day, 7.69% less than 75 mg daily and 1.43% more than 150 mg daily. One hundred and sixty nine who had used aspirin withdrew. Common causes of the withdrawal were as follows: 43.2% for fear of potential long-term side effects, 22.5% for discomfort after taking, 17.2% for economic reasons, 15.4% for no doctors' re-prescription and 1.8% for inconvenience in prescription. Total of 4546 were men aged 50 and above or women aged 60 and above, of whom 1844 (40.6%) were taking aspirin. Three hundred and four patients had diabetes, of whom 122 (40.1%) were taking aspirin. Four thousand two hundred and seventeen patients had dyslipidaemia, of whom 1541 (36.5%) were taking aspirin. One thousand six hundred and twenty five had coronary heart diseases, 1149 (70.7%) were taking aspirin. Four hundred and seventy five complicated with ischemic stroke, 292 (61.5%) were taking aspirin. Conclusion Most of the patients are taking an appropriate dose of aspirin. There is still a considerable number of patients with indications for aspirin who did not take it. We should strengthen the education of patients and physicians to increase the use of aspirin to prevent cardiovascular and cerebrovascular events.
Title: Aspirin usage in patients with essential hypertension
Description:
Objective To investigate the use of aspirin in patients with essential hypertension complicated with different risk factors and clinical conditions.
Method Epidemiological cross-sectional survey was used.
Through face to face questionnaire, patients with essential hypertension patients in 20 cities in China were assessed for aspirin consumption.
Results Total of 6483 patients with hypertension were enrolled; 3287 (50.
7%) were male and other 3195 (49.
3%) were female.
Their mean age was 62.
21 years, mean blood pressure was 142.
8/86 mm Hg, mean hypertension course was 10.
46 years.
A total of 2301 (35.
5%) patients were taking aspirin, of which 88.
05% of patients were using aspirin dose 75–150 mg/day, 7.
69% less than 75 mg daily and 1.
43% more than 150 mg daily.
One hundred and sixty nine who had used aspirin withdrew.
Common causes of the withdrawal were as follows: 43.
2% for fear of potential long-term side effects, 22.
5% for discomfort after taking, 17.
2% for economic reasons, 15.
4% for no doctors' re-prescription and 1.
8% for inconvenience in prescription.
Total of 4546 were men aged 50 and above or women aged 60 and above, of whom 1844 (40.
6%) were taking aspirin.
Three hundred and four patients had diabetes, of whom 122 (40.
1%) were taking aspirin.
Four thousand two hundred and seventeen patients had dyslipidaemia, of whom 1541 (36.
5%) were taking aspirin.
One thousand six hundred and twenty five had coronary heart diseases, 1149 (70.
7%) were taking aspirin.
Four hundred and seventy five complicated with ischemic stroke, 292 (61.
5%) were taking aspirin.
Conclusion Most of the patients are taking an appropriate dose of aspirin.
There is still a considerable number of patients with indications for aspirin who did not take it.
We should strengthen the education of patients and physicians to increase the use of aspirin to prevent cardiovascular and cerebrovascular events.

Related Results

Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Objective: To evaluate and provide management strategies for patients with aspirin or nonselective nonsteroidal antiinflammatory drug (NSAID) sensitivity. Data Sources: Literature ...
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Aspirin, commonly used for prevention of cardiovascular and cerebrovascular diseases, has been found to possess protective effects against cancer development in the Western populat...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Aspirin promotes ferroptosis by attenuating Nrf2 in triple-negative breast cancer
Aspirin promotes ferroptosis by attenuating Nrf2 in triple-negative breast cancer
Abstract Purpose Recent research has found that patients who receive aspirin might have a reduced risk of breast cancer. However, how aspirin influences cancer remains con...
Abstract 226: Adherence to Aspirin Therapy for Primary Prevention of Coronary Artery Disease and Cerebrovascular Accidents
Abstract 226: Adherence to Aspirin Therapy for Primary Prevention of Coronary Artery Disease and Cerebrovascular Accidents
Cardiovascular disease is the leading cause of death in the United States. One simple, overlooked, and easily available therapy can reduce this risk: aspirin. Low dose aspirin redu...
Abstract 3681: Aspirin acetylates glucose 6 phosphate dehydrogenase and inhibits its activity in colon cancer cells.
Abstract 3681: Aspirin acetylates glucose 6 phosphate dehydrogenase and inhibits its activity in colon cancer cells.
Abstract Epidemiological studies have demonstrated a significant correlation between regular aspirin use and reduced colon cancer incidence and mortality. Although a...
Abstract 3501: Aspirin modulates oncogene expression in hct 116 colon cancer cells
Abstract 3501: Aspirin modulates oncogene expression in hct 116 colon cancer cells
Abstract Aspirin is a 100 year old Non-steroidal anti-inflammatory drug (NSAID). Beside its use a cardio-protective agent, it is also used for treatment of headache,...

Back to Top